Valneva will provide 40,000 doses of its chikungunya vaccine Ixchiq to French overseas territory La Réunion as part of efforts to curb the spike in disease cases on the island. Valneva confirmed ...

During the last three months, 6 analysts shared their evaluations of Valneva VALN, revealing diverse outlooks from bullish to bearish. The following table provides a quick overview of their recent ...

Saint-Herblain (France), March 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 24, 2025, of its 2024 Universal ...

Shares of VALN stock opened at $7.17 on Friday. Valneva has a 1 year low of $3.62 and a 1 year high of $9.50. The firm’s fifty day simple moving average is $6.34 and its 200 day simple moving ...

Valneva, a company specializing in vaccine development, reported strong financial results for the first quarter of 2024. The company achieved a significant year-over-year increase in product sales ...

Saint Herblain (France), March 24, 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it is responding to the chikungunya outbreak that is rapidly ...

Saint-Herblain (France), March 20, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported its consolidated financial results for the year ended ...

Saint-Herblain (France), March 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 24, 2025, of its 2024 Universal Registration ...

Analysts expect Valneva to post earnings of ($0.22) per share and revenue of $55.64 million for the quarter. Valneva Trading Up 0.1 % NASDAQ VALN opened at $6.80 on Monday.